Posted by Dato Seri John Lu > 2020-09-23 09:11 | Report Abuse

Dumb dumb holding until RM3

Posted by Stockhunter88 > 2020-09-23 09:18 | Report Abuse

Why so short sighted compare against carepls? At least TG la, TP rm30.. Loss making no healthcare background also nvm

Posted by Boneka > 2020-09-23 10:02 | Report Abuse

With a population of 1.3 billion to draw from, more than four times as much as the population of the US, China has over 2.3 million in active service, with an additional 1.1 million as reserves and military police.

That adds up to 3.4m shots of vaccines!
This augurs well for Solutn :-)

Posted by Agjl > 2020-09-23 10:07 | Report Abuse

Scary and risky ride....will take my pittance profits and chow first....all the best!

Posted by Bemillion > 2020-09-23 10:10 | Report Abuse

Hahaa active counter

BRIEF-Solution Group Enters Into MoU With Cansino Biologics Inc.
Aug 19 (Reuters) - Solution Group Bhd SOLUTN :

* SOLUTION GROUP BHD- ENTERED INTO MOU WITH CANSINO BIOLOGICS INC.

* SOLUTION-MOU FOR COLLABORATION ON POTENTIAL COVID-19 VACCINE BY CANSINOBIO & BEIJING INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES

* SOLUTION GROUP - SGB EXPECTS COLLABORATION WILL CONTRIBUTE POSITIVELY TO EARNINGS IN FUTURE

Source text for Eikon: Further company coverage: SOLUTN

((Reuters.Briefs@thomsonreuters.com;)

Trade on own risk

Posted by Yyyyyy > 2020-09-23 10:25 | Report Abuse

Cansino got link to russian covid vaccine


https://www.theedgemarkets.com/article/malaysia-collaborating-russia-covid19-vaccine-%E2%80%94-mosti

Posted by Yyyyyy > 2020-09-23 10:25 | Report Abuse

https://www.clinicaltrialsarena.com/news/cansino-vaccine-russia-trial/

Posted by Bemillion > 2020-09-23 11:01 | Report Abuse

+news

News
Russia approves Phase III trial of CanSino’s Covid-19 vaccine
3rd September 2020 (Last Updated September 3rd, 2020 07:36)
Russia has granted approval for a Phase III clinical trial of China-based CanSino Biologics' Covid-19 vaccine candidate, developed with the Chinese military’s research arm.

Russia approves Phase III trial of CanSino’s Covid-19 vaccine
Previous trial data showed that the vaccine candidate was safe and induced immune responses. Credit: fotoblend on Pixabay.
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.

Russia has granted approval for a Phase III clinical trial of China-based CanSino Biologics’ Covid-19 vaccine candidate, developed in alliance with the Chinese military’s research arm.

The Phase III trial of the Ad5-nCoV vaccine candidate has been launched in Moscow, following health ministry authorisation. CanSino will work with NPO Petrovax Pharm to conduct the trials in Russia.

A statement from the CanSino said: “The company is currently driving the international multi-centre phase three clinical trial for Ad5-nCoV and plans to conduct the clinical trial for Ad5-nCoV in several countries.”

The Russian approval comes after CanSino and the National Research Council (NRC) of Canada terminated their collaboration on the development of the vaccine.

Trials in Canada were expected to start in July but were cancelled after failing to receive vaccine shipments from China.

CanSino plans to test its vaccine candidate in multiple countries globally. The company expects to enrol a total of approximately 40,000 participants.

Last month, the company announced plans to initiate a Phase III trial of Ad5-nCOV in Saudi Arabia. This trial is set to enrol about 5,000 subjects.
The vaccine candidate is made up of a harmless cold virus known as adenovirus type-5 (Ad5) to deliver genetic material from the coronavirus into the body.


Data from previous trials showed that the candidate was safe and triggered immune responses in most participants. CanSino conducted the first and second phase studies of Ad5-nCoV in China.

The first phase evaluated three different doses of the vaccine in 108 volunteers in China from 16 to 27 March while the second phase tested two doses in 603 subjects from 11 to 16 April.

Results revealed a favourable efficiency profile, with Covid-19 antibodies observed in the plasma of the participants. Few side effects were reported, primarily with low vaccine doses.

Related Companies

Posted by oilwaterman > 2020-09-23 11:05 | Report Abuse

why russia covid cases keep increasing if vaccine is working

Posted by Bemillion > 2020-09-23 11:08 | Report Abuse

Too much oil less water..hahaaa

Posted by Akino Tok Tok > 2020-09-23 11:26 | Report Abuse

Yesterday everybody was Kongfu Fighting : now everybody is ice slope skating.

Posted by pang72 > 2020-09-23 12:42 | Report Abuse

Tak boleh leh...

Posted by birdparadise > 2020-09-23 12:43 |

Post removed.Why?

Posted by limontea > 2020-09-23 13:20 | Report Abuse

Today Bursa Red Sea. Politik oh politik...

Posted by ongzhenghong > 2020-09-23 13:27 | Report Abuse

https://www.klsescreener.com/v2/announcements/view/3232959

Posted by HuatEveryday > 2020-09-23 13:49 | Report Abuse

Announcement wrong timing...

Posted by Orlando > 2020-09-23 14:02 | Report Abuse

Syndicates politically well connected

Knew abt Anwar so last pump n lari d?

Posted by HuatEveryday > 2020-09-23 14:05 | Report Abuse

So change government change vaccine distributor? Hahahahaha

Posted by Orlando > 2020-09-23 14:05 | Report Abuse

Or even Anwars men?

Posted by bigprice > 2020-09-23 14:10 | Report Abuse

all panic sell.

Posted by Orlando > 2020-09-23 14:11 | Report Abuse

Political uncertainty for even 3 days is enough...

Posted by newuser9021 > 2020-09-23 14:25 | Report Abuse

with today noon announcement, it will be a green day with Solution.. pity those who sell in below 70c..

Posted by kentrade888 > 2020-09-23 14:30 | Report Abuse

0093 SOLUTN SOLUTION GROUP BERHAD
OTHERS

OTHERS
REGISTRATION, MANUFACTURING AND COMMERCIALISATION AGREEMENT BETWEEN SOLUTION
GROUP BERHAD ("SGB" OR "THE COMPANY") AND CANSINO BIOLOGICS INC.
You are advised to read the entire contents of the announcement or attachment.
To read the entire contents of the announcement or attachment, please access
the Bursa website at http://www.bursamalaysia.com


23/09/2020 01:11 PM


Ref Code: 202009233000040

Posted by Stockhunter88 > 2020-09-23 14:34 | Report Abuse

News out, 3 minutes show, done

Posted by kentrade888 > 2020-09-23 14:36 | Report Abuse

The opportunity to buy bargain hunting is here.

Posted by wkkht > 2020-09-23 14:40 | Report Abuse

When the news fades, it will definitely rush upwards.

Posted by newuser9021 > 2020-09-23 14:43 | Report Abuse

a piece of advise.. if you think you are done here, check out JCY 5161 counter. good sale is going on now..

Posted by wkkht > 2020-09-23 14:50 | Report Abuse

方案工程上挑80仙/敏源
Nanyang Wed, Sep 23, 2020 12:02am - 14 hours ago



马股周二在金融股领涨下成功重返1500线上，富时隆综指的交投走势反弹了。

富时隆综指于9月22日闭市时以1505.78点报收，按日涨6.35或0.42%。整日交投波幅介于16.97（1494.93-1511.90）点间。

上升股项为431只，而下跌股项为600只。

方案工程（SOLUTN，0093，创业板）于9月22日闭市时收69仙，按日涨5仙或7.81%。

方案工程的30分钟图表走势，于9月22日的交投走势沿着它的上升趋势线（B1:B2）上爬升。

它的30分钟平滑异同移动均线指标（MACD），于9月22日的交投走势处于一个调整的格局。

它处于“0”支撑线上波动，方案工程的后市交投走势，或会出现一段短线回试它的下限支撑线的支撑（B1:B2）。

方案工程的日线图表走势于回试后，或会显现一段反弹走势，它或会挑战70-80仙的阻力水平。

Posted by shlyw > 2020-09-23 15:00 | Report Abuse

Tomorrow will fly very high.

Posted by AlIGATO > 2020-09-23 15:12 | Report Abuse

Really !!

Posted by shlyw > 2020-09-23 15:19 | Report Abuse

Please give a limit up.

Posted by Dato Seri John Lu > 2020-09-23 15:21 | Report Abuse

Good news but I still waiting the agreement sign between solution and MOH

Posted by HTCS > 2020-09-23 15:32 | Report Abuse

Wah .. same pattern like Bintai yesterday. FIFO

Posted by Aristgan92 > 2020-09-23 15:32 | Report Abuse

Hoot 9 E, no give face
no hoot sure regret

Posted by Aristgan92 > 2020-09-23 15:33 | Report Abuse

Will have more news publish very soon

Posted by Bemillion > 2020-09-23 15:39 | Report Abuse

.We refer to the Company’s announcements dated 19 August 2020, 24 August 2020, 27 August 2020 and 2 September 2020. The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that our subsidiary, Solution Biologics Sdn Bhd (“SOLBIO”), had on 23 September 2020 signed a Registration, Manufacturing and Commercialisation Agreement (“the Agreement”) with CanSino Biologics Inc. (“CanSinoBIO”, SHSE: 688185, HKEX:06185).



Please refer to the attachment for further details.



This announcement is dated 23 September 2020.

Posted by LOOK009 > 2020-09-23 15:43 | Report Abuse

The price has been increasing.

Posted by LOOK009 > 2020-09-23 15:52 | Report Abuse

Solution Group subsidiary signs agreement with CanSino to distribute novel coronavirus vaccine
TheEdge Wed, Sep 23, 2020 03:38pm - 13 minutes ago


KUALA LUMPUR (Sept 23): Solution Group Bhd's subsidiary Solution Biologics Sdn Bhd and China-based CanSino Biologics Inc today signed a registration, manufacturing and commercialisation agreement, which will enable Solution Biologics to market and distribute in Malaysia the novel coronavirus vaccine developed by CanSino.

In a statement to Bursa Malaysia today, Solution Group said Solution Biologics will register with Malaysia's National Pharmaceutical Regulatory Agency to apply for the market authorisation certificate.

Solution Group said Solution Biologics "will establish a state-of-the-art fill and finish facility" to host a technology transfer for the filling, finishing and final quality control of CanSino's recombinant novel coronavirus vaccine.

The facility will be established at Solution Biologics' current premises at PT13796, Jalan Tekno Usahawan 2, Technology Park Malaysia in Bukit Jalil here.

"CanSino will collaborate with Solution Biologics in obtaining the necessary approvals [including the marketing authorisation] for the purposes of the registration and commercialisation of the product in Malaysia.

"Upon the product's registration, CanSino will be partnering with Solution Biologics in supplying to Solution Biologics of bulk product for further manufacturing (fill and finish) of the finished product, its final quality control release and its commercialisation by Solution Biologics in Malaysia," Solution Group said.

"Upon the successful implementation of the terms, interests and the intention of the parties as set out in the agreement, Solution Group expects the collaboration will contribute positively to its earnings in the future," Solution Group said.

At 3.14pm today, Solution Group's share price rose four sen or 5.8% to 73 sen for a market capitalisation of RM223.51 million. The stock saw some 107 million shares traded.

Posted by Forever > 2020-09-23 15:54 | Report Abuse

Can in now?

Posted by mecomeherejoke > 2020-09-23 16:02 | Report Abuse

https://www.theedgemarkets.com/article/solution-group-subsidiary-signs-agreement-cansino-distribute-novel-coronavirus-vaccine

Posted by tuapuikia > 2020-09-23 16:04 | Report Abuse

limit up ?

Posted by mecomeherejoke > 2020-09-23 16:10 | Report Abuse

Forever Can in now?

I don't know but I entered 0.700, have to monitor closely

Posted by HuatEveryday > 2020-09-23 16:11 | Report Abuse

Flush flush flush.... and slow and steady up up up

Posted by LOOK009 > 2020-09-23 16:12 | Report Abuse

There is no limit up today and we have to wait for tomorrow.

Posted by hahman > 2020-09-23 16:18 | Report Abuse

4pm le, where got show??

Posted by HuatEveryday > 2020-09-23 16:18 | Report Abuse

Don’t limit up.... steady up better

Posted by Bemillion > 2020-09-23 16:22 | Report Abuse

All her friends same vaccine glove.. morre than $1... looks promising .TA seems ok

Posted by limontea > 2020-09-23 16:30 | Report Abuse

sell on news. But can always wait for opportunity to enter again.

Posted by mf > 2020-09-23 16:33 | Report Abuse

rebound

Posted by mf > 2020-09-23 16:35 | Report Abuse

rebound